Literature DB >> 2776893

Disappearance of exogenously administered human chorionic gonadotropin.

M D Damewood1, W Shen, H A Zacur, W D Schlaff, J A Rock, E E Wallach.   

Abstract

Concentrations of human chorionic gonadotropin (hCG) were measured after intramuscular hCG administration in 34 patients undergoing ovarian stimulation in an in vitro fertilization program. Serum hCG levels were detectable by an immunoenzymetric assay up to 14 days after injection. Individual variation in hCG concentration after injection could be minimized by expressing the daily hCG level as a fractional distribution of the value observed 36 hours after hCG administration (hCG0). In nonpregnant patients, less than 10% of the hCG0 value was found on day 10. The disappearance rate measured 36 hours after injection of hCG was exponential with a mean half-life of 2.32 days. These findings are significant for ovarian stimulation protocols, including exogenous hCG, with respect to timing and accuracy of quantitative pregnancy testing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776893     DOI: 10.1016/s0015-0282(16)60906-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  27 in total

1.  Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS.

Authors:  Juan C Castillo; Juan Garcia-Velasco; Peter Humaidan
Journal:  J Assist Reprod Genet       Date:  2012-01-12       Impact factor: 3.412

Review 2.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

3.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

Review 4.  Ovarian manipulation in ART: going beyond physiological standards to provide best clinical outcomes.

Authors:  Israel Ortega; Juan A García-Velasco; Antonio Pellicer
Journal:  J Assist Reprod Genet       Date:  2018-07-28       Impact factor: 3.412

5.  Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trial.

Authors:  Sonia Morales Zarcos; Pamela Valdivieso Mejía; Carla Donado Stefani; Pascual Sánchez Martin; Fernando Sánchez Martin
Journal:  JBRA Assist Reprod       Date:  2017-09-01

6.  Effects of two human chorionic gonadotropin doses administered to the ovarian states during the in vitro fertilization and embryo transfer program.

Authors:  Mingxing Ma; Jialin Wang; Lijun Xu; Qinxi Zhang; Botao DU; Xiaoying Jiang; Qingli Shi; Lili Zhou; Baoxin Li; Hidekazu Saito; Hirohisa Kurachi
Journal:  Biomed Rep       Date:  2014-11-20

7.  Natural IVF cycles may be desirable for women with repeated failures by stimulated IVF cycles.

Authors:  Toshiki Matsuura; Yuji Takehara; Hirotsune Kaijima; Shokichi Teramoto; Osamu Kato
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

8.  Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.

Authors:  C Schmidt-Sarosi; D R Kaplan; P Sarosi; M N Essig; F L Licciardi; M Keltz; M Levitz
Journal:  J Assist Reprod Genet       Date:  1995-03       Impact factor: 3.412

9.  Maternal smoking and developmental changes in luteinizing hormone (LH) and the LH receptor in the fetal testis.

Authors:  Paul A Fowler; Siladitya Bhattacharya; Jörg Gromoll; Ana Monteiro; Peter J O'Shaughnessy
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

10.  Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.

Authors:  Jacob Christ; Christopher N Herndon; Bo Yu
Journal:  J Assist Reprod Genet       Date:  2021-01-20       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.